Press Releases

BOSTON, Aug. 22, 2019 /PRNewswire/ -- Biofourmis, a fast-growing global leader in digital therapeutics based in Boston, has added two global pharmaceutical senior ex

SANTA CLARA, Calif., Aug. 22, 2019 /PRNewswire/ -- Glassbeam, Inc. today revealed several innovative technology enhancements in its Rules & Alerts engine that make it dramatically easier and faster for users in large organizations to create and maintain rule based notifications. This new functionality now comes bundled with machine learning algorithms for trigg

RANCHO CUCAMONGA, Calif., Aug. 22, 2019 /PRNewswire/ -- New World Medical, Inc., a privately held ophthalmic company dedicated to developing innovative medical devices for the treatment of glaucoma, announced the launch of the Ahmed® ClearPath™ glaucoma drainage device. Developed in close partnership with glaucoma surgeons, the Ahmed ClearPath is the newe

Appoints veteran VP Operations Hires high profile cannabis sommelier LAVAL, QC, Aug. 22, 2019 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT) is pleased to announce two new additions to its team to support the company's rapid growth. Neptune has appointed

DENVER, Aug. 22, 2019 /PRNewswire/ -- DAVITA INC. (NYSE: DVA), "DaVita," a Fortune 500® health care provider focused on transforming care delivery to improve quality of life for patients around the globe and the largest provider of kidney care services in the U.S., announced today the final results of its modified "Dutch auction" t

NEW YORK, Aug. 22, 2019 /PRNewswire/ -- Oscar, the first health insurance company built to make health care easy, today announced that it will expand to cover individuals and families in six new states and a total of 12 new markets in 2020, pending regulatory approval. This is the third consecutive year Oscar has significantly expanded its footprint, and this expansion

LINKÖPING, Sweden, Aug. 22, 2019 /PRNewswire/ -- Linköping, Sweden – August 22, 2019 – The international medical imaging IT and cybersecurity company

STOCKHOLM, Aug. 22, 2019 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its interim report for the January - June 2019 is now available on the company's website:

LUND, Sweden, Aug. 22, 2019 /PRNewswire/ -- "We are executing according to plan. Our lead candidate BI-1206 has shown encouraging initial data in hematological cancers, and has now also entered clinical trials in solid cancer," Martin Welschof, CEO BioInventFinancial informationSecond quarter 2019

STOCKHOLM, Aug. 22, 2019 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sob